luoxin pharmaceuticals group stock (002793.SZ) announced that Chengdu Deyixinhua private equity, a shareholder holding more than 5% of the company's shares, traded...
Zhijing Finance APP news, luoxin pharmaceuticals group stock (002793.SZ) announced that Chengdu Deyixinhua private equity investment partnership enterprise (limited partnership) (hereinafter referred to as "Deyi Chengdu"), Kelamayi Deyihengjia private equity investment partnership enterprise (hereinafter referred to as "Deyi Hengjia"), Kelamayi Deyixinhua private equity investment partnership enterprise (hereinafter referred to as "Deyi Xinhua"), and Ms. Yan Jinxia signed a "Stock Transfer Agreement" on October 8, 2024. Deyi Chengdu intends to transfer 41.692359 million shares of its unrestricted tradable shares to Ms. Yan Jinxia through the agreement; Deyi Hengjia intends to transfer 35.789757 million shares of its unrestricted tradable shares to Ms. Yan Jinxia through the agreement; Deyi Xinhua intends to transfer 24.961414 million shares of its unrestricted tradable shares to Ms. Yan Jinxia through the agreement. The total transaction value is 0.41 billion yuan.
After the agreement transfer, Deyi Chengdu, Deyi Hengjia, and Deyi Xinhua will no longer hold company shares. Deyi Health and Desheng Health collectively hold 10.640378 million shares of the company, accounting for 0.98% of the total share capital of the company, and the aforementioned shareholders will no longer be shareholders holding more than 5% of the company; Ms. Yan Jinxia holds 0.102 billion shares of the company, accounting for 9.42% of the total share capital of the company, becoming a shareholder holding more than 5% of the company.